Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • alex.maxwell21 alex.maxwell21 Aug 25, 2011 6:03 PM Flag

    royalties improve if Teva gets approved

    I know, the trial is over the other drug before the FDA from MNTA's pipeline. However, I do believe that MNTA filed a lawsuit against Teva for patent infringement related to Teva's attempted generic, which would have competed with copaxone. Things are about to get interesting, and I disagree, I own MNTA and I believe that Teva will get approved eventually, hopefully the other drug is on the market by then and we are all millionares...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Your still a little bit fuzzy.

      On Lovenox, MNTA has sued TEVA over their attempt to get a generic Lovenox approved that would slash MNTA's revenue. This trial is over a year away because the parties do not consider it urgent. [hint]

      On Copaxone, TEVA is suing Sandoz (MNTA) to stop MNTA's generic Copaxone (TEVA's sole non generic drug of note), that trial is partially in progress, and partially very soon. If Sandoz/MNTA lose they then the generic Copox revenue is delayed until 2014 (assuming FDA ..)

      Will TEVA "ever" get tL approved? Ever is a long time. But will the present version be approved? It has been 8 years now, and will be over 10 years by trial time. Most would say that this means TEVA is at square one on this.

 
MNTA
10.84+0.26(+2.46%)3:27 PMEDT